Naya Biosciences, INC. (IVF) SEC Filings — 2024
27 SEC filings for Naya Biosciences, INC. (IVF) in 2024.
Filings
- NAYA Biosciences Files S-1 Registration — S-1 · Dec 17, 2024
- NAYA Biosciences Files 8-K/A Amendment — 8-K/A · Dec 12, 2024
- NAYA Biosciences Files 2023 10-K/A Amendment — 10-K/A · Nov 19, 2024
- Naya Biosciences, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- NAYA Biosciences Files 8-K — 8-K · Nov 8, 2024
- INVO Bioscience Reports Material Agreements & Asset Changes — 8-K · Oct 15, 2024
- INVO Bioscience Enters Material Agreement, Incurs Financial Obligation — 8-K · Oct 1, 2024
- INVO Bioscience Faces Delisting Concerns, Restates Financials — 8-K · Sep 20, 2024
- INVO Bioscience Files 8-K for Equity Sale — 8-K · Sep 18, 2024
- INVO Bioscience Q2 2024 10-Q Filed — 10-Q · Aug 14, 2024
- INVO Bioscience Enters Material Definitive Agreement — 8-K · Jul 5, 2024
- INVO Bioscience Faces Nasdaq Delisting Warning — 8-K · Jun 20, 2024
- INVO Bioscience, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- INVO Bioscience Files 8-K: Material Agreement & Equity Sales — 8-K · May 6, 2024
- INVO Bioscience Files Amended 10-K for Fiscal Year Ended December 31, 2023 — 10-K/A · Apr 29, 2024
- INVO Bioscience Faces Delisting and Agreement Termination — 8-K · Apr 19, 2024
- INVO Bioscience files 10-K/A amendment — 10-K/A · Apr 17, 2024
- INVO Bioscience, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
- INVO Bioscience Files 8-K: Agreements, Debt, and Equity Sales — 8-K · Apr 11, 2024
- INVO Bioscience Files 8-K Amendment — 8-K/A · Apr 2, 2024
- INVO Bioscience Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 1, 2024
- INVO Bioscience Files 10-K/A Amendment for Fiscal Year 2022 — 10-K/A · Mar 27, 2024
- INVO Bioscience Secures $1.5M Loan — 8-K · Mar 1, 2024
- Intracoastal Capital Amends INVO Bioscience Stake — SC 13G/A · Feb 6, 2024
- INVO Bioscience Files 8-K on Jan 19 Event; Nasdaq Listing Confirmed — 8-K · Feb 1, 2024
- INVO Bioscience Amends 8-K on Material Agreement, Equity Sales — 8-K/A · Jan 10, 2024
- INVO Bioscience Reports Unregistered Equity Sales, Material Agreement — 8-K · Jan 3, 2024